PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
04-Aug-2020 New Deployment Model Optimizes LIMS Implementation in the Amazon Web Services Cloud Thermo Fisher Scientific
04-Aug-2020 Mallinckrodt plc Reports Earnings for the Second Quarter 2020 and Highlights Pipeline Advancements Mallinckrodt plc
04-Aug-2020 The new Marketplace for Pharma Business Opportunities is now online Raucon
04-Aug-2020 TRANSFORM, THE WORLD’S MOST TECHNOLOGICALLY ADVANCED TRAINING PLATFORM, LAUNCHES TO THE PHARMACEUTICALS INDUSTRY TODAY 3t Energy Group
04-Aug-2020 Vivoryon Therapeutics AG: Vivoryon Receives IND Approval for Varoglutamstat's (PQ912) Phase 2 Study in Alzheimer's Disease Vivoryon Therapeutics AG
04-Aug-2020 New data independently confirms and extends laboratory findings and expands safety profile of ATH434 Alterity Therapeutics Limited
03-Aug-2020 Immunic, Inc. Announces Proposed Public Offering of 5 Million Shares of Common Stock Immunic, Inc.
03-Aug-2020 Horizon, Prime Therapeutics team with PillPack to improve members' pharmacy experience Prime Therapeutics LLC
03-Aug-2020 Ophthalmic Drug Delivery Development - Trials and Tribulations workshop SMi Group Ltd
03-Aug-2020 PAION ANNOUNCES APPROVAL OF COMPASSIONATE USE PROGRAM FOR REMIMAZOLAM IN BELGIUM PAION AG
03-Aug-2020 Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior Janssen Pharmaceutical Companies of Johnson & Johnson
03-Aug-2020 New speaker session with Kiniksa Pharmaceuticals at Pre-filled Syringes East Coast 2020 SMi Group Ltd
03-Aug-2020 Sales Q2/2020 and H1/2020: Continued dynamic development in the U.S. with double-digit growth rates; international and German business strongly impacted by COVID-19 pandemic aap Implantate AG
03-Aug-2020 LUMICKS enters collaboration with Glycostem to enhance NK cell-mediated immunotherapy Sciad Newswire
03-Aug-2020 Polyphor announces second positive Data Safety Monitoring Board recommendation to continue Phase III FORTRESS study without modifications Polyphor AG
03-Aug-2020 VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock VistaGen Therapeutics
03-Aug-2020 Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China Innovent Biologics, Inc.
03-Aug-2020 Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China Innovent Biologics, Inc.
02-Aug-2020 Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis Immunic, Inc.
02-Aug-2020 Siemens Healthineers plans acquisition of Varian Siemens Healthineers AG